Analyst Rating Update on Kindred Healthcare (KND)

Kindred Healthcare (NYSE:KND) : Zacks Investment Research ranks Kindred Healthcare (NYSE:KND) as 2, which is a Buy recommendation. 1 research analysts consider that the stocks fundamentals point to a bright future, hence they rate the stock as a Strong Buy. 1 other analysts are mildly bullish on the stock and favor a Buy. Not everyone is convinced about the stocks future, hence, the stock receives 1 Sell recommendation. A total of 5 analysts believe that the stock has a limited upside, hence they advise a Hold. The average broker rating of 8 research analysts is 2.75, which indicates as a Hold.

Kindred Healthcare (NYSE:KND) : The highest short term price target forecast on Kindred Healthcare (NYSE:KND) is $17 and the lowest target price is $11. A total of 6 equity analysts are currently covering the company. The average price of all the analysts is $14.92 with a standard deviation of $2.33.

Company shares have received an average consensus rating of Hold for the current week

Kindred Healthcare (NYSE:KND): stock turned positive on Tuesday. Though the stock opened at $10.74, the bulls momentum made the stock top out at $11.08 level for the day. The stock recorded a low of $10.66 and closed the trading day at $10.9, in the green by 3.91%. The total traded volume for the day was 675,868. The stock had closed at $10.49 in the previous days trading.

In an insider trading activity, Diaz Paul J, director of Kindred Healthcare, Inc had purchased 50,000 shares on November 10, 2015 in a transaction. The price per share was $12.53 and the total amount of the disclosed transaction was $626,500.The Insider information was disclosed with the Securities and Exchange Commission in a Form 4 filing. This information is based on open market transaction at the market prices.

Kindred Healthcare, Inc. is a healthcare services company that through its subsidiaries operates transitional care (TC) hospitals, inpatient rehabilitation hospitals (IRFs), nursing centers, assisted living facilities, a contract rehabilitation services business and a home health and hospice business across the United States. The Company operates through five segments: hospitals, nursing centers, skilled nursing rehabilitation services (SRS), hospital rehabilitation services (HRS) and home health and hospice services. The Companys hospital division provides long-term acute care services to medically complex patients. The Companys nursing center division operates through 90 nursing centers and seven assisted living facilities in 18 states. Its rehabilitation division provided rehabilitation services primarily in hospitals and long-term care settings. Its care management division primarily provided home health, hospice and private duty services from 143 locations in 13 states.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.